The pandemic influenza A (H1N1) infection has been shown to cause significant morbidity in children. 1 Gastrointestinal (GI) manifestation, including vomiting and diarrhea, has been reported in 2.8-36% of infected patients. [1] [2] [3] Despite the high rate of the GI symptoms, the virus has not been isolated from the GI track in humans. 4 We present the case of a 9-year-old girl in whom the initial presentation of the H1N1 infection mimicked a flare-up of GI GVHD. This girl had a history of myelodysplastic syndrome and had undergone a mismatched unrelated cord blood transplant at 2 years of age. The preparative regimen consisted of CY, TBI and antithymocyte globulin. The GVHD prophylaxis was with cyclosporine and prednisone. Her course was complicated by acute and extensive chronic GVHD. She had several episodes of flare-up of her GI GVHD manifesting as anorexia, vomiting and profuse diarrhea. Her more recent flare-up was at 3 months before her presentation. She was maintained on tacrolimus and prednisone 1 mg/kg every other day. She has required increase in her steroid dosing owing to flare-up of her GVHD. She was admitted to our hospital with vomiting, profuse diarrhea and severe abdominal pain of 1 week duration. After admission to the hospital, she was placed on gut rest and i.v. nutrition for suspected GI GVHD flareup. Infectious workup of the diarrhea included bacterial and viral cultures that were negative. Her vomiting, diarrhea and abdominal pain worsened; therefore, she underwent a colonoscopy and endoscopy on hospital day 4. The colon was grossly normal in appearance, and the stomach had mild erythema. Histological examination of the stomach was negative for histological findings of GVHD but suspicious for possible viral infection (Figure 1 ). On hospital day 5 she developed fever, and so an extensive infectious disease workup was undertaken, including blood cultures, and nasal and throat swabs for respiratory viruses (including influenza) by PCR, which was negative. On hospital day 9, the gastric biopsy specimen that was sent for viral cultures revealed the presence of the pandemic H1N1. Therapy with oral oseltamivir 45 mg twice a day was started. On hospital day 11 she developed respiratory distress, requiring transfer to the pediatric intensive care unit for positive pressure ventilation. A chest radiograph revealed bilateral interstitial lung disease and a small pleural effusion. She had a rapid deterioration in her respiratory condition requiring mechanical ventilation. A bronchoalveolar lavage revealed the H1N1 virus by PCR and viral cultures. Despite aggressive supportive care, the patient died of respiratory failure on hospital day 20.
Four previous cases of H1N1 infection have been reported in patients following SCT. 5, 6 In all four cases the patients presented with classic influenza-like symptoms, including fever, malaise and upper respiratory tract infection, and none of the reported patients had isolated GI symptoms. Our case represents the first report of isolation of the H1N1 virus from human GI tissue in association with abnormal histological findings on biopsy. At the time of biopsy the patient had isolated GI symptoms and no fever or upper respiratory tract symptoms. A PCR testing failed to identify the influenza virus from the upper respiratory track at the time of biopsy, ruling out the possibility of nasopharyngeal contamination during the stomach biopsy. Diarrhea, vomiting and abdominal pain are all common manifestations of GVHD flare-up in patients following allo-SCT. This case emphasizes the importance of GI biopsy in making the correct diagnosis. GI manifestation of H1N1 might precede the development of respiratory symptoms, and clinicians should have a high index of suspicion in post-transplant patients in the peak influenza season. 
